Buy or promote: Stock recommendation by brokers for April 9, 2025

Macquariehas maintained its ‘outperform’ ranking on Titan with a goal worth of Rs 4,000. Analysts mentioned that the corporate within the Jan-March interval reported wholesome jewelry gross sales development that was above estimates. The development was led by double-digit development in ticket measurement with single-digit purchaser development. They mentioned Titan’s wholesome development in This autumn was encouraging and enhances confidence of their earnings per share (EPS) estimates.
BoFASecurities has given a ‘neutral’ ranking on Tata Motors with a decrease goal worth of Rs 655. Analysts mentioned for the Jan-march interval, JLR reported good updates however it didn’t matter anymore for the reason that new tariff proposals within the US and the associated pause in gross sales volumes created uncertainty for the close to time period on its enterprise and money burn. They mentioned India enterprise was valued at Rs 475/share and probably a bear case however JLR doesn’t warrant zero worth essentially. Key elements to be careful for are India-UK bilateral commerce offers, help and pricing actions by its rivals.
CLSAhas given an ‘outperform’ ranking on Bajaj Finance with a goal worth of Rs 11,000. Analysts mentioned FY25 noticed slower development and moderated return on fairness as a consequence of greater credit score prices. With asset high quality enhancing, they count on robust development from FY26.
Morgan Stanley has an ‘equal weight’ ranking on Macrotech Developers with a goal worth of Rs 1,230. Analysts count on the corporate’s FY26 development could be pushed by new initiatives in Pune and Bangalore. Although the corporate’s pre-sales for Jan-march missed estimates, collections have been robust.
Goldman Sachs has a ‘buy’ ranking on Piramal Pharma with a goal worth of Rs 275. Analysts imagine the corporate is positioned for top-quartile revenue development. Its profit-before-tax margin is predicted to rise from about 3% in FY24 to over 16% by FY28. Its development drivers could be CDMO enterprise, capability growth and turnaround of ICH enterprise.
Disclaimer: The opinions, analyses and proposals expressed herein are these of brokerage and don’t mirror the views of The Times of India. Always seek the advice of with a certified funding advisor or monetary planner earlier than making any funding selections.